Skip to Content

Sprix Approval History

  • FDA approved: Yes (First approved May 14th, 2010)
  • Brand name: Sprix
  • Generic name: ketorolac tromethamine
  • Dosage form: Nasal Spray
  • Previous name: ROX-888
  • Company: Roxro Pharma, Inc.
  • Treatment for: Pain

Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.

Development History and FDA Approval Process for Sprix

DateArticle
May 17, 2010Approval Roxro Announces FDA Approval of Sprix
Feb  6, 2009Roxro Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide